Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
25,062,413
-
Share change
-
+779,460
-
Total reported value
-
$263,156,774
-
Price per share
-
$10.50
-
Number of holders
-
91
-
Value change
-
+$7,503,955
-
Number of buys
-
34
-
Number of sells
-
54
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2016
As of 31 Mar 2016,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,062,413 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, NWQ INVESTMENT MANAGEMENT COMPANY, LLC, DIMENSIONAL FUND ADVISORS LP, FRANKLIN RESOURCES INC, ARIEL INVESTMENTS, LLC, Boston Partners, VANGUARD GROUP INC, ROYAL BANK OF CANADA, HEARTLAND ADVISORS INC, and ROYCE & ASSOCIATES LP.
This page lists
91
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.